Colacci A, Perocco P, Vaccari M, Mazzullo M, Albini A, Parodi S, Taningher M, Grilli S
Istituto Nazionale per la Ricerca sul Cancro (IST-Genova), Università di Bologna, Italy.
Jpn J Cancer Res. 1990 Aug;81(8):786-92. doi: 10.1111/j.1349-7006.1990.tb02646.x.
1,1,2,2-Tetrachloroethane (1,1,2,2-TTCE) was shown to be capable of inducing in vitro transformation of BALB/c 3T3 cells (clone A-31) either in the presence or in the absence of S9 activating system using an amplification-transformation (level-II) assay by reseeding confluent cells from each treatment and allowing additional rounds of cell replication. In the absence of metabolic activation, the highest assayed dose (1000 micrograms/ml), exerting the highest toxicity, was the only transforming dose. Lower doses of 1,1,2,2-TTCE were capable of transforming BALB/c cells in the presence of S9 activating system, the dose of 500 micrograms/ml exerting the highest transforming activity. The number and size of transformed foci recognized in the level-II plates were a function of the number of cells reseeded in the amplification assay. Foci obtained in the presence of S9 activating systems were larger in size, more deeply basophilic, and exhibited denser multilayering of constituent cells than foci recognized in the absence of exogenous metabolic activation.
使用扩增转化(二级)试验,通过重新接种来自每种处理的汇合细胞并进行额外轮次的细胞复制,结果表明,无论有无S9活化系统,1,1,2,2-四氯乙烷(1,1,2,2-TTCE)都能够在体外诱导BALB/c 3T3细胞(A-31克隆)发生转化。在没有代谢活化的情况下,所检测的最高剂量(1000微克/毫升),其毒性最高,是唯一的转化剂量。较低剂量的1,1,2,2-TTCE在S9活化系统存在的情况下能够转化BALB/c细胞,500微克/毫升的剂量具有最高的转化活性。在二级平板中识别出的转化灶的数量和大小是扩增试验中重新接种的细胞数量的函数。与在没有外源性代谢活化的情况下识别出的灶相比,在S9活化系统存在的情况下获得的灶尺寸更大,嗜碱性更强,并且组成细胞的多层堆积更密集。